{
  "docId": "019de070-a7f9-700d-9686-c0d9e2559ea7",
  "docSlug": "49e1302a11c2e640ac427a516c932653",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 82 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 25,
  "pageCount": 82,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "Includes a bar chart showing quarterly organic growth trends and text summaries of product-specific performance.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a7f9-700d-9686-c0d9e2559ea7/25",
  "deckHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7",
  "deckJsonHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7.json",
  "deckAnchorHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Global Solta Organic Growth",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfa0cbf9-5df5-4142-a21b-2a5bd602cb22",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.48,
        "x": 0.48,
        "y": 0.7
      },
      "kind": "list",
      "text": "Additional Key Products: DUOBRII TRx growth 53% vs 5% market. SILIQ revenue growth 39% in FY20.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c38e46d-a694-4672-b011-ce8cf9db37ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.48,
        "x": 0.48,
        "y": 0.55
      },
      "kind": "list",
      "text": "JUBLIA: 3% revenue growth in FY20. TRx growth of 18% vs flat market.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4389bf3-38b1-4710-a339-eafa2b593286",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.48,
        "x": 0.48,
        "y": 0.15
      },
      "kind": "list",
      "text": "THERMAGE: 47% growth in FY20, 46% in 4Q20. Driven by China and 'Zoom culture'. 2021 catalysts include market penetration and new product launch.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1b0a2e5-4091-42c0-a95d-6492445159c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Recovery in Progress: Organic revenue recovered to pre-COVID-19 levels in 4Q20 vs. 4Q19. Driven by strong performance from Global Solta which saw organic revenue growth of 31%. Organic revenue decline of (3%) in FY20 vs. FY19, driven by COVID-19.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "380bf00b-7f6b-4e61-b937-f43260362ce2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.25,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. See Slide 2 and Appendix for further non-GAAP information. 2. Organic growth/change... 3. IQVIA NPA monthly.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "514320e5-bad2-459c-8f2f-6f5f40a291e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "Ortho Dermatologics 4Q20 and FY20 Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0aa55105-bea6-4cb2-b974-3c53e0b0a396",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "df04f19f-527a-4539-a05c-6bcf34cc344a",
      "evidence": "Recovery in Progress: Organic revenue recovered to pre-COVID-19 levels in 4Q20 vs. 4Q19.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 30,
      "from": 15,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "3f929d33-08a9-4163-8b41-a09e812667a2",
      "evidence": "The presentation emphasizes the importance of execution, growth, and accelerating strategic alternatives.",
      "position": 0,
      "objective": "Highlighting the cost of inaction and the benefits of strategic alternatives",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}